6 risultati
BACKGROUND OF THE INVENTION
Throughout this application, citations for various publications are provided within parentheses in the text. The disclosures of these publications are hereby incorporated in their entirety by reference into this application in order to more fully describe the state of the
BACKGROUND OF THE INVENTION
Throughout this application, citations for various publications are provided within parentheses in the text. The disclosures of these publications are hereby incorporated in their entirety by reference into this application in order to more fully describe the state of the
BACKGROUND OF THE INVENTION
Throughout this application, citations for various publications are provided within parentheses in the text. The disclosures of these publications are hereby incorporated in their entirety by reference into this application in order to more fully describe the state of the
FIELD OF THE INVENTION
The present invention relates to the field of active specific immunotherapy of cancer and among other things provides a vaccine composition for producing or increasing the antibody immune response against N-glycolylated gangliosides, especially N-glycolyl GM3 (NGcGM3), which
FIELD OF THE INVENTION
The present invention relates to the field of active specific immunotherapy of cancer and among other things, provides vaccine compositions for producing or increasing the antibody immune response against gangliosides, especially N-glycolyl GM3 (NGcGM3) and N-acetyl GM3
CROSS REFERENCE TO RELATED APPLICATIONS
This application is filed under the provisions of 35 U.S.C. .sctn.371 of International Application PCT/KR02100894 filed May 14, 2002, claiming priority to KR2001-27943 filed May 22, 2001.
TECHNICAL FIELD
The present invention relates to a lectin protein